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Mice Deficient in the Serine/Threonine Protein Kinase VRK1 Are Infertile
Due to a Progressive Loss of Spermatogonia1
Matthew S. Wiebe, R. Jeremy Nichols,3 Tyler P. Molitor, Jill K. Lindgren, and Paula Traktman2
Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin
ABSTRACT
The VRK1 protein kinase has been implicated as a pro-
proliferative factor. Genetic analyses of mutant alleles of the
Drosophila and Caenorhabditis elegans VRK1 homologs have
revealed phenotypes ranging from embryonic lethality to mitotic
and meiotic defects with resultant sterility. Herein, we describe
the first genetic analysis of murine VRK1. Two lines of mice
containing distinct gene-trap integrations into the Vrk1 locus
were established. Insertion into intron 12 (GT12) spared VRK1
function, enabling the examination of VRK1 expression in situ.
Insertion into intron 3 (GT3) disrupted VRK1 function, but
incomplete splicing to the gene trap rendered this allele
hypomorphic (;15% of wild-type levels of VRK1 remain).
GT3/GT3 mice are viable, but both males and females are
infertile. In testes, VRK1 is expressed in Sertoli cells and
spermatogonia. The infertility of GT3/GT3 male mice results
from a progressive defect in spermatogonial proliferation or
differentiation, culminating in the absence of mitotic and
meiotic cells in adult testis. These data demonstrate an
important role for VRK1 in cell proliferation and confirm that
the need for VRK1 during gametogenesis is evolutionarily
conserved.
gametogenesis, infertility, kinases, proliferation, protein kinase,
signal transduction, spermatogenesis, spermatogonia, testis, VRK1
INTRODUCTION
Spermatogenesis is capable of producing as many as 100
million spermatozoa per day in humans and up to 1.6 billion
sperm per day in pigs, making the testes one of the most highly
proliferative adult tissues [1]. This high rate of cell division is a
vital biological process, and perturbations to its regulation have
serious consequences. Errors in spermatogonial mitosis can
alter the delicate balance between self-renewal and differenti-
ation needed for long-term gametogenesis, thus resulting in
infertility. Mitotic errors may also lead to aneuploidy as well as
to chromosomal breakage and instability, all of which are
hallmarks of cancer cells. To avoid the propagation of such
errors, checkpoints capable of halting cell growth are present
throughout the cell cycle. Many of these checkpoints and,
indeed, many normal cell-cycle transitions are regulated by
dynamic protein phosphorylation. Given the importance of
phosphorylation in orchestrating the events of the cell cycle,
understanding the vital contributions of protein kinases to the
regulated cell proliferation that drives gametogenesis and the
disregulated cell proliferation that drives oncogenesis is of
fundamental importance.
Recent evidence indicates that the vaccinia-related kinase-1
(VRK1) has roles in regulating gametogenesis and may
contribute to tumor formation [2–8]. VRK1 overexpression
has been associated with several types of cancer [4], and most
recently, the overexpression of VRK1 has been highlighted as
part of a gene expression signature that is prognostic of poor
clinical outcome in patients with breast cancer [9]. VRK1 is
one of three VRK family members that branch from the casein
kinase family. The naming of the VRK genes reflects the high
degree of homology between the VRK proteins and the B1
protein kinase encoded by vaccinia virus, the prototypic
poxvirus and the virus used in the successful vaccination
campaign to eradicate smallpox [10]. VRK1 and VRK2 cDNAs
were first isolated from a library enriched for fetal-specific
genes, and Northern blot analysis indicated that the mRNAs for
both transcripts were found at elevated levels in highly
proliferative tissues [10]. VRK3 was identified later [11], and
its mRNA transcript also appears to be broadly expressed. The
three proteins show a significant degree of homology within
their catalytic domains, but they contain distinct extracatalytic
domains that mediate differing patterns of intracellular
localization and may contribute to substrate specificity.
VRK1 and VRK2 are active enzymes that localize to the
nucleus and intracellular membranes [12], respectively, and
VRK3 is a catalytically inactive pseudokinase that likely
functions as a scaffold protein [12–14]. These three paralogs
are present in the genomes of vertebrates, whereas Drosophila
melanogaster and Caenorhabditis elegans each encode a single
VRK that has been shown to play essential roles in mitosis and
meiosis [15, 16]. VRK orthologs are not present in budding or
fission yeast.
VRK1 has been implicated in modulating cell growth via
multiple intracellular signal transduction cascades (for review,
see [17]). A variety of stress-responsive transcription factors,
such as TP53, ATF2, and JUN, can be phosphorylated and
stimulated by VRK1 [3, 5, 6]. It has also been reported that
VRK1 can phosphorylate histone H3 on Thr3 and Ser10 [18];
these modifications are associated with the condensation of
mitotic chromatin. In addition, VRK1 has been shown to
phosphorylate CREB, a transcriptional activator that in turn
controls the expression of the key cell-cycle regulator cyclin D
[19]. Finally, the barrier to autointegration factor (BAF), which
plays an important role in nuclear reassembly late in mitosis,
was shown to be a highly efficient substrate for VRK1 in vitro
and in vivo. Phosphorylation of BAF blocks its ability to bind
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to DNA and inhibits its interaction with protein partners; in
vivo, phosphorylation of BAF is also associated with its exit
from the nucleus [12, 20].
Genetic studies examining VRK mutants in D. melanogast-
er and C. elegans have revealed phenotypes ranging from
embryonic lethality in the most severely affected organisms to
sterility in animals carrying hypomorphic alleles [15, 16].
Herein, we describe the first genetic analysis of VRK1 in a
mammal by characterizing two lines of mice containing gene-
trap insertions within the Vrk1 locus. These studies reveal that
depletion of VRK1 leads to progressive male infertility as a
result of a cessation of spermatogonial proliferation. These
findings substantiate results found in lower eukaryotes and
further establish the importance of VRK1 during cell
proliferation in the testes.
MATERIALS AND METHODS
Animals
C57B/6 mice were purchased from Charles River Laboratories. All mice
were maintained in the Medical College of Wisconsin animal colony under
specific pathogen-free conditions in accordance with National Institutes of
Health and institutional guidelines.
Generation and Evaluation of Vrk1 Chimeric Mice
The RRR178 and XH078 clones of mouse sv129/ola embryonic stem (ES)
cells in which a b-galactosidase/neoR (bgeo) gene-trap cassette had been
inserted into the Vrk1 locus were obtained from the Mutant Mouse Regional
Resource Center, University of California at San Francisco. (For the positioning
of these insertions within the Vrk1 locus, see Figs. 1A and 3A.) The RRR178
locus has the official symbol of Vrk1Gt(RRR178)Byg and hereafter will be referred
to as GT3. The XH078 locus has the official symbol of Vrk1Gt(X078)Byg and
hereafter will be referred to as GT12. The Medical College of Wisconsin
Transgenic Core Facility was employed to generate chimeric mice by injection
of these ES cells into C57BL/6 blastocysts, which were subsequently implanted
into pseudopregnant female CD1 mice. Male chimeras were mated to C57BL/6
females; agouti Aw pups born from these matings were further characterized to
monitor germline transmission of the gene-trapped locus. Inheritance of the
gene-trapped GT12 locus could be verified by assaying tail tips for b-
galactosidase (b-gal) activity (Xgal staining). Because the VRK1-GT3bgeo
fusion protein was not active in this assay, mice carrying the GT3 locus were
genotyped by Southern blot and PCR as described later.
Genotyping
Genomic DNA from targeted ES cells or from mouse tail tips was harvested
by immersion of the cells or tissue in lysis buffer (4 M urea, 0.5% Sarkosyl
[Sigma], 10 mM cyclohexane diamine tetraacetic acid, 0.1 M Tris [pH 8], 0.2
M NaCl, and 1 mg/ml of proteinase K) followed by isopropanol precipitation.
DNA was analyzed using standard Southern blot protocols employing probes
corresponding to exons 2–6 or 11–15, as shown in Supplemental Figures S1
and S2 (all Supplemental Data are available online at www.biolreprod.org).
Further Southern blot analysis of the GT12 locus was performed using probes 1
and 2, which map within intron 12 of the Vrk1 gene or bgeo, respectively.
Probe 1 was amplified from genomic DNA using primers Ex12ScreenUP (50-
TAGCTGCCTGCGGGGTGTCG-30) and Ex12ScreenDN (TGGGAGGCA-
GAGGCAAATGAATC-30); probe 2 was amplified from genomic DNA using
primers bgeoUP1 (5 0-TATACGAAGTTATCGCAGATCTGGAC-3 0) and
bgeoDN1 (50-AAATGTGAGCGAGTAACAACCCGTC-30).
PCR Screen
The precise site of the gene-trap insertion in the Vrk1 GT3 mice was
determined by sequence analysis of a PCR product amplified from genomic
DNA with the Ex3ScreenUP primer (50-TCTGCCTGATGTTGTGATGAG-
30), which anneals to sequences within Vrk1 intron 3, and the bgeoDN2 primer
(50-TGGCCTGTCCCTCTCACCTTC-30), which anneals to sequences within
the bgeo gene-trap cassette. The site of the GT12 insertion was determined
similarly, using the Ex12UP (50-GACATGGAGTGCTCAGACAC-30) primer,
which anneals within intron 12 of Vrk1, and the bgeoDN2 primer. Subsequent
genotyping of Vrk1 GT3 mouse tail tip DNA was performed using the primers
Ex3UP (5 0-ACTGATGGGGTCTGTGTTTC-30) and Ex3DN (5 0-GGAGT
TACTTCTTGGCGCTG-30), which span the insertion site, and the bgeo-
specific primers bgeoUP1 and bgeoDN1.
Xgal Staining of Frozen Sections
Adult testes were fixed for 1.5 h in 4% paraformaldehyde and saturated
stepwise in PBS with 10%, 30%, and then 50% sucrose. Tissues were then
immersed in OCT medium, frozen in liquid nitrogen, and cut in 10-lm sections
that were mounted on slides for storage at208C. Slides were warmed to room
temperature and then fixed in 0.2% paraformaldehyde for 10 min on ice. They
FIG. 1. Genotypic analysis of the murine Vrk1 locus; confirmation of gene-trap insertion within intron 12. A) Schematic representation of the gene-
trapped GT12 Vrk1 locus is shown, with numbered boxes representing the exons. Exon 1 is not translated, exons 13 and 14 are excluded from some splice
variants, and exons 2–12 and 15 are present in all isoforms. Exons 8 and 9 encode key catalytic residues (kinase domains VI and VII) and exon 11 the
nuclear localization signal (NLS), as noted. The position of the GT12 bgeo insertion is shown. PCR products used to distinguish the wild-type (WT) locus
from one containing the b-Geo insertion are indicated. B) PCR genotyping of tail tip DNA. WT primers span the site of the GT12 insertion (as shown in the
above schematic, A) and only amplify a product from the WT Vrk1 allele. Amplification of a product with the bgeo primers, which lie within the gene-trap
insertion, confirms the presence of a gene-trapped allele.
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were then washed briefly in wash buffer (0.1 M sodium phosphate [pH 7.4],
0.02% NP40, 0.01% deoxycholate, and 2 mM MgCl
2
) and overlayed with b-gal
stain (wash buffer plus 1 mg/ml of Xgal, 5 mM potassium ferrocyanide, and 5
mM potassium ferricyanide). Testis sections shown were stained for 3 h in a
humid chamber at 378C.
Immunohistochemistry
Tissues were harvested and fixed overnight in zinc formalin, embedded in
paraffin, and cut into 4-lm sections. Sections were dewaxed in Citrisolv (Fisher)
and rehydrated stepwise through decreasing concentrations of ethanol. Antigen
retrieval was performed in 10 mM citric acid buffer (pH 6.0) for 10 min in a
958C water bath. Primary antibody incubations using the mouse anti-PLZF (sc-
28319), mouse anti-PCNA (anti-proliferating cell nuclear antigen; sc-56), or
goat anti-c-Kit (sc-1494) were performed overnight (Santa Cruz Biotechnolo-
gy). The rat GCNA (germ cell-specific nuclear antigen) monoclonal antibody
(kindly provided by Dr. George Enders, University of Kansas Medical Center,
Kansas City, KS) was used at a 1:100 dilution in an overnight incubation. When
mouse primary antibodies were employed, the biotin-conjugated secondary
antibody included in the M.O.M. Immunodetection Kit (Vector Laboratories)
was used. For the GCNA staining, a biotin-conjugated goat anti-rat secondary
antibody (559286; BD Biosciences) was used. For the c-Kit staining, a biotin-
conjugated rabbit anti-goat secondary antibody (BA-5000; Vector Laboratories)
was used. Staining was then visualized following treatment with Elite ABC
Reagent (Vector Laboratories) and incubation with diaminobenzidine reagent.
All images shown are representative of sections observed from at least two
mice; quantitation was done by counting stained cells within each tubule (n
value shown) of a random field.
Semiquantitative RT-PCR
Tissues were harvested from wild-type (þ/þ) and Vrk1 GT3/GT3 mice of the
ages indicated. Total RNA was isolated using RNeasy Plus spin columns
(Qiagen). Spleen samples were subjected to an additional on-column DNase
treatment. RT-PCR was performed on 2 lg of total RNA using Superscript III
Reverse Transcriptase (Invitrogen) and random primers according to the
manufacturer’s specifications. Equivalent cDNA volumes were used as template
in semiquantitative PCR reactions containing [a-32P]dATP (1.6 lCi/nmol).
Reactions were performed using the following Vrk1-specific primers: upstream:
US1, 50-GAAGTTCGTACTACGCTGTGGACC-30, and US2, 50-CACTTTCA
CAACACAGGGCG-30; downstream: DS1, 50-GACGCGCCCTGTGTTGT
GAAA-30, and DS2, 50-GTACCGATAAGCAAGGCCATAGTCTA-30. Ampli-
fication of b-actin sequences was performed using primers b-Actin AS, 50-
CTAGAAGCATTGCGGTGGACGATGG-3 0, and b-Actin S, 5 0-
TGACGGGGTCACCCACACTGTGCCC-30. The upstream primers amplify
sequences found in both wild-type and gene-trapped transcripts, whereas the
downstream primers only amplify sequences found in full-length Vrk1 mRNAs.
The latter primers provide an estimate of gene-trap ‘‘splice-around’’ activity in the
GT3 mice. The number of amplification cycles for Vrk1 and b-actin genes was
chosen to fall into the exponential phases of amplification (25 and 27 cycles,
respectively). The level of amplified products was quantitated by PhosphorImager
analysis using ImageQuant software. For each tissue, a ratio of the resulting PCR
products, (wt
D
/GT3
D
)/(wt
U
/GT3
U
), was calculated to assess the reduction of full-
length mRNA in the GT3 mice versus the wild-type mice. For amplification of Kit
ligand transcript, the primers used were KLUS, 50-CCCTGAAGACTCGGGCC
TA-30, and KLDS, 50-CAATTACAAGCGAAATGAGAGCC-30.
Immunoblot Analysis
Freshly harvested tissues were lysed in ice-cold extraction buffer (20 mM
Tris [pH 7.4], 100 mM NaCl, 1% TX-100, 0.05% SDS, and 2 mM MgCl
2
)
containing 1 lg/ml of pepstatin, 1 lg/ml of leupeptin, 1 mM PMSF, 1 mM
NaF, 5 nM calyculin A, and 25 U/ml of Benzonase (Sigma) for 15 min. NaCl
was then added to a final concentration of 500 mM, and incubation was
continued for 15 min, after which the sample was clarified by sedimentation at
14 0003 g for 10 min. The concentration of total protein in the clarified lysates
was determined using the BCA Protein Assay Kit (Thermo Scientific).
One-hundred micrograms of each lysate were subjected to immunoblot
analysis with the following antibodies: a rabbit polyclonal antiserum raised
against a peptide corresponding to amino acids 3–18 of mouse VRK1 (Bethyl),
rabbit a-VRK1 (Sigma), mouse a-PCNA (Santa Cruz Biotechnology), or rabbit
a-histone H3 phosphoSer10 (Upstate). Quantitation of the immunoreactive
signals was performed using an AlphaImager documentation system and
FluorChem 8900 software.
RESULTS
VRK1 Expression Within Testis Is Limited to Sertoli Cells
and Spermatogonia
To characterize the role of VRK1 in vivo, we obtained two
gene-trapped lines of murine ES cells from Baygenomics (now
available from the International Gene Trap Consortium) with
the goal of producing gene-targeted mice. These ES lines each
contain a bgeo insertion, the location of which has been
mapped by 50 rapid amplification of cDNA ends (RACE)
analysis to different introns of the murine Vrk1 locus on mouse
chromosome 12 (Fig. 1; see also Fig. 3). The splice acceptor
site at the 50 end of the bgeo sequences and the poly-A addition
site at the 30 end lead to the expression of a fusion mRNA that
initiates with the first exon of Vrk1 and terminates after the
bgeo sequences. The first ES cell line we employed (ID:
XH078) contains an insertion within intron 12 of Vrk1; this
locus will be referred to as GT12. The VRK1-bgeo fusion
protein that would be expressed from this locus lacks only 10–
54 (depending on the isoform [12]) of the 441 amino acids
found in the full-length VRK1 protein. This fusion protein
retains the kinase domain and the nuclear localization signal
and, thus, likely mimics the wild-type protein in both function
and intracellular localization.
Germline-competent chimeric mice were generated follow-
ing blastocyst injection with this line of ES cells, and we
established colonies of heterozygous þ/GT12 mice. These
mice had a normal appearance and were fertile. Initial
genotyping of these mice was accomplished by Southern blot
analysis, which verified the insertion of tandem, back-to-back,
bgeo insertions within intron 12 (Supplemental Fig. S1).
Subsequently, we mapped the precise location of the 50 end of
the bgeo insertion to þ312 of intron 12, which allowed us to
FIG. 2. VRK1 is expressed in the basal layer of the seminiferous tubule in
both Sertoli cells and spermatogonia. A) Representative tubule within a
GT12/GT12 testis, following formalin fixation and H&E staining, is shown.
The GT12/GT12 tubules exhibit wild-type morphology and cellular
content. B–D) Frozen sections of testes dissected from 11-wk-old mice
were assayed in situ for b-gal activity. A wild-type tubule (B) and GT12/
GT12 tubules (C and D). Arrows shown in C point to some of the b-galþ
Sertoli cells. Arrowheads shown in D highlight some of the b-galþ
spermatogonia. Original magnification310.
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use PCR to rapidly and accurately genotype subsequent
generations of mice. Two primer pairs were used; primer pair
WT (wild type) spans the insertion site and, under our
experimental conditions, only yields an amplified product in
wild-type or heterozygous mice (Fig. 1B, top). The bgeo
primer pair amplifies a region of the gene-trap insert (Fig. 1B,
bottom). Genotypic analysis of the F
2
progeny from þ/GT123
þ/GT12 matings yielded þ/þ, þ/GT12, and GT12/GT12 pups
in the predicted mendelian ratios. Moreover, the size, behavior,
overall health, and life span of the GT12/GT12 mice did not
differ from those of their wild-type littermates.
During initial examination of the VRK1-bgeo expression
profile by Xgal staining, we found that intact testes harvested
from GT12/GT12 mouse stained strongly blue, whereas wild-
type testes exhibited no staining (data not shown). This
confirms and extends previous studies indicating that murine
Vrk1 mRNA is highly expressed in the testis, suggesting that
VRK1 may have a role in murine gametogenesis [10]. As
expected from the wild-type phenotype of the GT12/GT12
mice, the seminiferous tubules within these testes showed a
normal histological organization and contained the full
complement of characteristic cell types (Fig. 2A). Frozen
sections of the þ/þ and GT12/GT12 testes were stained with
Xgal to reveal which cell types expressed the VRK1-bgeo
fusion protein. No staining was observed in the þ/þ samples
(Fig. 2B). As seen in two representative GT12/GT12 tubules
(Fig. 2, C and D), the Xgal staining was restricted to cells in the
basal layer. This basal layer contains the spermatogonial stem
cells (type A) and the type B spermatogonia to which they give
rise. Also present are the large Sertoli cells, which give both
mechanical support and signaling cues to most, if not all, cell
types within the tubule. The Sertoli cell nuclei often adopt a
somewhat triangular shape, whereas spermatogonia have
significantly smaller, round nuclei. These distinctive nuclear
FIG. 3. Genotypic and expression analysis
of the GT3 Vrk1 locus. A) Schematic
representation of the gene-trapped GT3
Vrk1 locus. The murine Vrk1 locus is
shown, with numbered boxes representing
the exons as described for Figure 1. The
position of the GT3 bgeo insertion is shown.
NLS, nuclear localization signal. B) Geno-
typing PCR. Wild-type (WT) primers span
the site of the GT3 insertion (as shown
above, A), only amplifying a product when
a wild-type VRK1 allele is present. bgeo
primers confirm the presence of a gene-
trapped allele. C) RT-PCR. Tissues were
harvested from 16-wk-old þ/þ and Vrk1
GT3/GT3 mice. Vrk1-specific cDNA se-
quences (as well as a b-actin control) were
amplified by semiquantitative RT-PCR using
the primers shown in the schematic. The
upstream primers (black arrows) amplify
sequences found in both full-length and
gene-trapped transcripts. The relative level
of total Vrk1 mRNA in þ/þ versus GT3/GT3
tissues was calculated; the fold-difference is
shown beneath the appropriate lanes. The
downstream primers (gray arrows) amplify
sequences found only in full-length mRNAs
and, hence, provide an estimate of the
frequency with which the gene trap is
spliced around in the GT3/GT3 mice. The
fold-difference in the level of the full-length
Vrk1 mRNA in þ/þ versus GT3/GT3 tissues
(shown beneath middle panel) was calcu-
lated after normalizing to the total Vrk1
mRNA levels found in each tissue.
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morphologies allowed us to determine that both Sertoli cells
(Fig. 2C, arrows) and spermatogonia (Fig. 2D, arrowheads)
stained positive with Xgal, indicating that VRK1 is expressed
in these cell types. We did not observe expression in meiotic
cells, spermatids, or sperm. We further confirmed the identity
of the stained cells by counterstaining the Xgal-treated sections
with DAPI (data not shown), taking advantage of the
distinctive nuclear staining of each of these cell types. (Sertoli
cells have large, euchromatic nuclei that stain poorly with
DAPI except for their distinctive nucleoli. Spermatogonia have
smaller, round nuclei with multiple heterochromatic regions.)
GT3 Locus Is a Hypomorphic Allele that Leads to Reduced
Expression of VRK1
The second ES cell line that we obtained from Baygenomics
contains a bgeo insertion in intron 3 of VRK1 (ID: RRR178);
this allele will be referred to henceforth as GT3. The GT3 locus
thus expresses a protein containing only the N-terminal 72
amino acids of VRK1 fused to bgeo. Thus, in contrast to the
nearly full-length VRK1 in the GT12 mice, the GT3 VRK1
protein would be highly truncated and catalytically inert,
because it is missing all of the kinase domain except the
Walker A and B boxes and is also missing the C-terminal
region containing the nuclear localization signal (Fig. 3). These
ES cells were also used to produce transgenic mice, which
were subsequently bred to yield þ/GT3 and GT3/GT3
progeny. As with the GT12 mice, initial genotyping of these
mice was accomplished by Southern blot analysis, which
verified the site of bgeo insertion (Supplemental Fig. S2).
Subsequently, we used RACE analysis to map the precise
location of the 50 end of the bgeo insertion to þ6174 of intron
3, which allowed us to genotype mice by PCR using primer
pairs specific for the wild-type and bgeo locus (Fig. 3, A and
B).
Genotypic analysis of the F
2
progeny from þ/GT33þ/GT3
matings yielded þ/þ, þ/GT3, and GT3/GT3 pups in the
predicted mendelian ratios; this conclusion was supported by
chi-square analysis. Moreover, the size and life span of the
GT3/GT3 mice did not differ from their wild-type littermates.
These observations were somewhat surprising, because VRK is
essential in both D. melanogaster and C. elegans [15, 16].
Mice encode two catalytically active VRK enzymes; therefore,
redundancy between the functions of VRK1 and VRK2 might
render the loss of VRK1 less detrimental. RT-PCR analysis of
RNA extracted from liver, kidney, and testis indicated that
VRK2 expression was not elevated in GT3/GT3 mice (not
shown); nevertheless, endogenous levels of VRK2 might be
sufficient to overcome the loss of VRK1.
Another explanation for the viability of GT3/GT3 mice was
suggested by the observation that in many cases, gene-trapped
mice retain some expression of the wild-type protein as a result
of incomplete splicing to the bgeo insertion. In essence, the
gene-trapped allele is often hypomorphic rather than null [21].
To examine the level to which GT3/GT3 mice express full-
length VRK1, we performed semiquantitative RT-PCR of
RNA extracted from multiple tissues. Two primer sets were
employed. The Vrk1 upstream primer set (shown by black
arrows in Fig. 3B) spans exons 1–3 and, thus, should amplify
the same product from both the trapped Vrk1-bgeo transcript
and any full-length Vrk1 transcript that is produced. In contrast,
the Vrk1 downstream primer set (shown by gray arrows in Fig.
3B) spans exons 3–7 of Vrk1; because these exons are not
present in the Vrk1-bgeo transcript, these primers will only
yield an amplified product from full-length mRNA generated
by ‘‘splicing around’’ the trap. Primers specific to b-actin were
also used as an internal control.
Previous studies have indicated that Vrk1 transcript is
ubiquitously expressed [22], and indeed, the upstream primers
yielded a Vrk1 amplicon in all samples tested (Fig. 3B, top).
FIG. 4. The testes of adult GT3/GT3 mice are reduced in size and display a loss of cellularity. A, top) Photograph illustrating the relative size of testes
from 12-wk-old þ/þ, þ/GT3, and GT3/GT3 mice. A, bottom) Testes from mice of the indicated ages were measured lengthwise; data are depicted
graphically. Error bars represent standard error between samples; at least five testes were measured for each age of mice. For the samples harvested at 7–8
and 12 wk, a statistically significant difference is found between the sizes of the þ/þ and GT3/GT3 testes, as determined by the Mann-Whitney rank sum
test. *P , 0.03, **P , 0.001. B) H&E-stained sections of the testis and epididymis taken from 12-wk-old þ/þ and GT3/GT3 mice. With the rare exception
(one example marked with asterisk), the seminiferous tubules in the GT3/GT3 testis lack most spermatogonia and all meiotic cells. Similarly, the lumens of
the GT3/GT3 epididymis are devoid of sperm. Original magnification34.
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However, the level of Vrk1 expression appeared to vary
between the different tissues harvested from wild-type mice.
Highly proliferative tissues, such as the testis and spleen,
contained more Vrk1 mRNA than nonproliferative tissues, such
as the liver and kidney (Fig. 3B, top, compare lanes 1 and 7 to
lanes 3 and 5). The fact that Vrk1 exhibits increased expression
in highly proliferative tissues was intriguing in light of its
previously attributed roles in mitosis and meiosis in D.
melanogaster, C. elegans, and tissue culture cells [15, 16, 23].
For most tissues, no difference was found in the upstream
amplicon levels between the þ/þ and GT3/GT3 samples (Fig.
3, top, compare lanes 1 and 2, lanes 3 and 4, and lanes 5 and 6),
indicating that expression of the Vrk1 mRNA is unchanged by
the bgeo insertion. In contrast, we consistently observed an
approximately 3.7-fold decrease in amplicon levels in the
spleen samples harvested from GT3/GT3 mice. This finding
suggests that either transcription of the Vrk1 gene is inhibited
by the bgeo insertion in the spleen or, more likely, that the cell
types that express Vrk1 are partially depleted from the GT3/
GT3 spleen.
The RT-PCR analyses performed with the Vrk1 downstream
primers (Fig. 3C, middle) allowed us to quantitate the
FIG. 5. VRK1-deficient testes show a progressive loss of cellularity and
absence of spermatogenesis with increasing postnatal age. Sections of
paraffin-embedded testes harvested from þ/þ or GT3/GT3 mice at 4, 6,
and 11 wk of age were stained with H&E. The image of the 6-wk-old þ/þ
tubule is subdivided into zones a, b, and c to indicate the location of
spermatogonia/Sertoli cells, meiotic cells, and elongated spermatids,
respectively. These cell types can also be found in some tubules of the 6-
wk-old GT3/GT3 mice, albeit at lower numbers, but are absent in older
GT3/GT3 mice. By 11 wk of age, only one basal layer of cells, which is
largely comprised of Sertoli cells (arrowheads), remains in the GT3/GT3
sample. Original magnification320.
FIG. 6. Vrk1 deficiency results in a loss of GCNAþ spermatogonia.
Sections of paraffin-embedded testes from adult (age, 12 wk) mice were
subjected to immunohistochemical analysis using an antibody specific for
the germ cell nuclear antigen (GCNA). The GCNA staining was observed
as expected in spermatogonia and cells proceeding through meiosis I in
þ/þ tubules (A), but very few cells in GT3/GT3 tubules (B) stained with the
GCNA antibody. The number of GCNAþ cells per tubule was determined
after examining many tubules (n value shown) from four testes of mice of
each genotype (C). Original magnification310.
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decrement in full-length Vrk1 mRNA in the GT3/GT3 tissues.
After normalizing to the signal obtained with the upstream
primers (total transcript levels), we calculated a deficiency in
full-length Vrk1 mRNA that ranged from 4.5- to 6.4-fold (80–
85% decrease) in the various adult tissues. Parallel studies were
also performed using tissues from 4-wk-old mice. The amount
of full-length VRK1 expressed in GT3/GT3 mice of this age
was also significantly reduced compared to þ/þ mice
(Supplemental Fig. S3). These RT-PCR data indicate the
GT3 allele is, indeed, hypomorphic and that GT3/GT3 mice
retain approximately 15–20% of the wild-type levels of full-
length Vrk1 mRNA in their tissues. This expression profile was
also observed at the protein level, as shown by immunoblot
analysis (Supplemental Fig. S4). (The absolute levels of full-
length Vrk1 mRNA are lowest in the GT3/GT3 spleen [20-fold
reduction relative to þ/þ]. As described earlier, we believe that
the observed loss of total Vrk1 transcripts in this tissue likely
results from a depletion of Vrk1-expressing cells in the GT3/
GT3 spleen.)
Male and Female GT3/GT3 Mice Are Infertile
As mentioned earlier, matings of þ/GT3 with þ/GT3 mice,
and of þ/GT12 with þ/GT12 mice, yielded F
2
progeny of all
predicted genotypes in the correct mendelian ratios. Thus, both
gene-trapped alleles support viability in the homozygous state.
Matings of GT12/GT123 GT12/GT12 mice were productive,
and we have maintained a colony of GT12/GT12 mice over
many generations. Thus, the GT12 allele supports both
viability and fertility in the homozygous state.
In contrast, the GT3 allele had quite a different impact. No
litters were obtained from multiple matings of GT3/GT3 males
with GT3/GT3 females, although copulation plugs were
observed and matings of þ/GT3 mice continued to be
productive over many generations. To determine whether this
fertility problem was gender specific, we mated nine GT3/GT3
males to þ/þ females and nine GT3/GT3 females to þ/þ
males. These matings were initiated when the GT3/GT3 mice
were 6–10 wk of age and were allowed to continue for 6–8 wk.
From the matings set up with the nine GT3/GT3 male mice, we
obtained only a single litter; one 6-wk-old GT3/GT3 male
fathered a litter but could produce no further litters despite
repeated attempts. None of the other eight GT3/GT3 males
were fertile. In addition, none of the nine GT3/GT3 females
produced any litters when mated to þ/þ males. Thus, in the
homozygous state, the GT3 allele renders both male and female
mice infertile.
VRK1-Deficient Testes Display Progressive Loss of Mitotic
and Meiotic Cells
Both male and female GT3/GT3 mice are infertile, but in the
present study, we focused on identifying the defect in males.
As shown in Figure 4A (top), a gross analysis of the testes of
adult þ/þ, þ/GT3, and GT3/GT3 mice revealed a clear
decrease in the size of the testis in the GT3/GT3 mice, although
the overall body sizes of all mice were comparable. When this
analysis was performed at various times of postnatal
development, we observed little difference in testis size at 2
or 4 wk of age (Fig. 4A, bottom). However, a few weeks after
puberty, the difference in size between the testes of þ/þ and
GT3/GT3 mice was readily observed and statistically signif-
FIG. 7. Vrk1 deficiency results in a progressive loss of markers of cellular
proliferation. A) Sections of paraffin-embedded testes from 4-wk-old and
adult (age, 14 wk) mice were subjected to immunohistochemical analysis
using an antibody specific for PCNA. At 4 wk of age, PCNA staining was
observed as expected in spermatogonia and early meiotic cells in both þ/
þ and GT3/GT3 tubules. However, by 14 wk, GT3/GT3 tubules contained
very few PCNAþ cells. Original magnification 310. B) The number of
PCNAþ cells per tubule was determined after examining many tubules (n
value shown) from four testes of adult mice of each genotype. C)
Immunoblot analysis of proliferative markers. Liver, spleen, and testis were
harvested from 4- and 14-wk-old mice. Whole-cell lysates were prepared,
and 100 lg of protein were subjected to electrophoretic fractionation.
Confirmation that the amounts of protein being analyzed were compa-
rable was obtained by Coomassie blue staining (top), and the levels of
PCNA and H3pser10 were visualized by immunoblot analysis. The
3
fold-changes in proliferative markers between 14-wk-old þ/þ and GT3/
GT3 mice are depicted beneath the appropriate bracketed lanes.
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icant (P , 0.03). The cellular basis for this difference in testis
size became apparent upon histological examination. While
hematoxylin and eosin (H&E)-stained sections of þ/þ testes
from 11- to 12-wk-old mice showed the expected complement
of mitotic spermatogonia and meiotic cells in each tubule, the
GT3/GT3 tubules appeared devoid of virtually all cell types
with the exception of Sertoli cells (Fig. 4B, left). Furthermore,
a stark difference was also seen in the epididymal tubules of
these mice. Whereas the lumens of more than 90% of
epididymal tubules of þ/þ mice contained sperm, none of
the tubule lumens in the 12-wk GT3/GT3 epididymis contained
sperm.
To determine the age of onset for this loss of cellularity, we
examined testes from younger mice beginning at 2 wk of age.
We found that þ/þ and GT3/GT3 testes were indistinguishable
at 2 wk (not shown) and 4 wk (Fig. 5) of age, before the onset
of puberty. At 6 wk of age, GT3/GT3 tubules displayed a range
of phenotypes. Some GT3/GT3 tubules, like their wild-type
counterparts, contained spermatogonia, the full complement of
cells in meiosis I, and round and elongated spermatids (marked
as a, b, and c, respectively, in the þ/þ sample shown in Fig. 5).
However, many GT3/GT3 tubules displayed a striking loss of
cellular density. As illustrated by the image in Figure 5, these
tubules showed a clear reduction in the number of meiotic cells
and spermatids. Some GT3/GT3 tubules (not shown) exhibited
what appeared to be a ‘‘Sertoli Cell Only’’ phenotype even at
this early age. Histological examination of epididymal sections
from 6-wk-old mice showed that whereas sperm were observed
in more than 90% of the lumens of þ/þ samples, sperm were
only seen in less than 20% of the lumens of GT3/GT3 samples
(not shown). GT3/GT3 mice examined between the ages of 7–
10 wk displayed an increasingly severe phenotype, with many
tubules showing reduced cellularity and an absence of meiotic
cells. By 11 wk, the GT3/GT3 tubules appeared to contain only
Sertoli cells (Fig. 5, arrowheads), whereas the wild-type testes
retained all cell types inherent to spermatogenesis.
VRK1 Deficiency Results in Progressive Loss of GCNAþ
and PCNAþ Spermatogonia
These data indicated a progressive defect in GT3/GT3 mice
characterized by a loss of spermatogenesis and a reduction in
the complexity of cell types within the seminiferous tubules.
We next set out to define more precisely the stage of
spermatogenesis that was affected by the VRK1 deficiency.
To address this question, we performed immunohistochemical
analyses of the seminiferous tubules using antibodies specific
for GCNA, PCNA, and KIT. GCNA has been shown to be
present in spermatogonial stem cells, mitotic spermatogonia,
and cells in the prediplotene stages of meiosis I [24]. In þ/þ
testes, GCNA staining was strongest in the peripheral
spermatogonia but also clearly present in cells undergoing
meiosis I (Fig. 6A). In comparison, adult GT3/GT3 testes were
largely devoid of GCNAþ tubules (Fig. 6B). Quantitation of
the number of GCNAþ cells per tubule in þ/þ and GT3/GT3
tubules revealed that approximately 80% of the GT3/GT3
tubules contained less than five cells per tubule, whereas 100%
of the þ/þ tubules had more than 40 GCNAþ cells per tubule
(Fig. 6C). We next examined PCNA staining, which is a more
specific marker of proliferating type A and B spermatogonia.
Strong PCNA-staining of the rapidly proliferating spermato-
gonia was seen in the testes harvested from 4-wk-old mice of
both the þ/þ and GT3/GT3 gentotype (Fig. 7A, top). In adult
þ/þ mice (age, 14 wk), abundant PCNAþ cells continued to
be observed (.40 PCNAþ cells/tubule), substantiating the
ongoing proliferation of spermatogonia in these mice. Howev-
er, PCNAþ cells were largely absent (,5 PCNAþ cells/
tubule) from more than 90% of GT3/GT3 tubules (Fig. 7A,
bottom, quantitated in Fig. 7B), revealing a severe deficit of
proliferating spermatogonia in these VRK1-deficient testes. To
further identify the stage at which spermatogenesis is blocked,
we also utilized an antibody specific for KIT, a well-
characterized marker of early spermatogonial differentiation
[25–27]. Whereas KITþ spermatogonia were clearly present in
þ/þ testis, adult GT3/GT3 tubules were devoid of any staining
(Supplemental Fig. S5), confirming the absence of differenti-
ating cells.
To complement these histological analyses of GT3/GT3
tissues, we performed immunoblot analyses of þ/þ and GT3/
GT3 tissue lysates (Fig. 7C). Because VRK1 has been
associated with cell proliferation, and because GT3/GT3 testes
have shown a loss of PCNAþ cells, we probed these extracts
with antibodies specific for the proliferative marker PCNA and
the mitotic marker phosphohistone H3(Ser10). In the samples
harvested from the 4-wk-old mice, PCNA levels did not vary
between þ/þ and GT3/GT3 samples, although a modest, but
reproducible, diminution in the level of H3(Ser10) was
FIG. 8. Proliferating spermatogonia are lost first during GT3/GT3 tubule
degeneration. Serial sections of testes from 8-wk-old þ/þ (A and B) and
GT3/GT3 (C–F) mice were stained with H&E (A, C, and E) or subjected to
immunohistochemistry using a PCNA-specific antibody (B, D, and F).
Those GT3/GT3 tubules containing an intermediate number of PCNAþ
cells were examined for the presence of other cell types and were found to
contain cells in meiosis I (arrows; bottom), round spermatids (arrowheads;
top) and elongated spermatids. Original magnification310.
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observed in the GT3/GT3 testis. The results were far more
striking in the samples harvested from adult mice. The levels of
PCNA in the GT3/GT3 spleen and testis were approximately
10-fold lower than those in the þ/þ samples (Fig. 7C, compare
lanes 9 and 10 and lanes 11 and 12). These data correlate well
with the dramatic loss of PCNAþ cells observed in GT3/GT3
testes by immunohistochemistry (Fig. 7A, bottom). The levels
of H3(Ser10) expression were also reduced in GT3/GT3
tissues, being threefold lower in spleen and 33-fold lower in
testis. Together, these data provide strong evidence that
depletion of VRK1 in the tissues examined severely compro-
mises cellular proliferation.
A block in the proliferation and/or differentiation of
spermatogonia would explain the absence of meiotic cells
and mature sperm in the adult GT3/GT3 mice. To further
demonstrate that the loss of spermatogonia is an early defect in
VRK1-deficient mice, we examined the tubules of 8-wk-old
GT3/GT3 mice, which are at an intermediate stage in tubule
degeneration. Many tubules were already devoid of spermato-
gonia. However, tubules were observed that contained only
10–20 PCNAþ spermatogonia but still contained elongated
spermatids, round spermatids (Fig. 8, C and D, arrowheads),
and cells in meiosis I (Fig. 8, E and F). Thus, in the tubules that
were shown to still be supporting meiosis and spermiogenesis
by H&E, a decline in PCNAþ cells was already evident (Fig.
8). These data argue that whereas the initial first wave of
spermatogenesis occurs fairly normally in GT3/GT3 mice, a
progressive loss of proliferating spermatogonia leads to a
subsequent arrest in spermatogenesis and, therefore, to tubule
collapse.
GT3/GT3 Mice Retain ZBTB16þ (PLZFþ) Spermatogonia
The loss of GCNAþ, PCNAþ, and KITþ spermatogonia in
GT3/GT3 mice led us to question whether a deficiency in
VRK1 leads to the absence or loss of undifferentiated
spermatogonial stem cells.To test this possibility, we examined
ZBTB16 (PLZF), which is expressed in type A spermatogonia
but is subsequently downregulated upon differentiation of these
cells [28, 29]. Thus, ZBTB16 is a marker of spermatogonial
stem cells and undifferentiated progenitor cells. As shown in
Figure 9, at 4 wk of age ZBTB16-expressing cells were visible
within the basal layer of the tubules of both wild-type and GT3/
GT3 testes. In adult mice, ZBTB16þ spermatogonia remained
present in testes of both genotypes. Quantitation of the number
FIG. 9. Vrk1-deficient mice retain early
PLZFþ (ZBTB16þ) spermatogonial stem
cells. Sections of paraffin-embedded testes
from 4-wk-old and adult (age, 14 wk) mice
were subjected to immunohistochemical
analysis using an antibody specific for the
early spermatogonial marker Zbtb16. A and
B) At 4 wks of age, ZBTB16 staining was
observed as expected in a subset of
peripheral spermatogonia in both þ/þ and
GT3/GT3 tubules. C and D) At 14 wk,
ZBTB16þ cells continue to be observed in
þ/þ and GT3/GT3 spermatogonia, with
some staining of the elongated spermatids
as well. E) The number of ZBTB16þ cells
per tubule was determined after examining
tubules (n value shown) from four testes of
adult mice of each genotype. Quantitation
represents the number of ZBTB16þ cells
per tubule, normalized to the relative area
of the tubule being examined. Only
ZBTB16þ cells at the basal aspect of the
tubule were counted in this analysis.
Original magnification 310.
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of ZBTB16þ cells at the periphery of each tubule revealed that
GT3/GT3 testes have at least as many, and perhaps slightly
more, ZBTB16þ cells per tubule as þ/þ testes when
normalized for the differences in tubule size between the
genotypes (4.44 vs. 3.25, respectively; P ¼ 0.02 by Mann-
Whitney rank sum test). In sum, these data indicate that
whereas active spermatogenesis occurs until puberty in GT3/
GT3 mice, the numbers of dividing spermatogonia and meiotic
cells drop precipitously in the first few weeks thereafter,
resulting in a concomitant loss of more mature spermatids.
However, because ZBTB16þ cells are not lost at these time
points, the phenotype of VRK1-deficient testes clearly is not
caused by a loss per se of the earliest spermatogonia. Rather, it
may be that these stem cells cannot differentiate into the more
rapidly dividing types of spermatogonia, or that these
spermatogonia are unable to proliferate when VRK1 is
depleted.
DISCUSSION
The mammalian vaccinia-related kinases (VRK1, VRK2,
and VRK3) form a distinct branch of the casein kinase family.
A single VRK homolog is encoded in the genomes of D.
melanogaster and C. elegans, and the early developmental
arrest that accompanies ablation of its expression indicates that
this kinase is essential [15, 30]. With regard to dVRK, also
known as NHK-1, the most severe alleles cause an embryonic
lethal phenotype, whereas milder, hypomorphic alleles spare
viability but cause male and female sterility [15, 31, 32].
Diminished NHK-1 function causes meiotic defects associated
with aberrant chromatin modification, spindle formation,
chromosome condensation, and karyomere formation. RNAi-
mediated depletion of NHK-1 in cultured S2 cells has adverse
effects on mitosis, leading to irregular chromosome condensa-
tion and to the presence of unaligned and lagging chromo-
somes [15]. Similar phenotypes have been observed for C.
elegans, in which siRNA-mediated depletion of cVRK was
shown to cause aberrant meiotic and mitotic spindles as well as
altered chromatin organization [30].
In mammals, VRK1 is the ortholog most closely related to
the D. melanogaster and C. elegans VRK enzymes, in that it is
catalytically active and exhibits a nuclear localization. The
present study represents to our knowledge the first genetic
analysis of the function of VRK1 in mice. The GT3 allele
contains a bgeo gene-trap insertion within intron 3 that should
lead to the expression of a highly truncated fusion protein
encoding only 72 amino acids of VRK1 fused to bgeo. As is
often seen [21], splicing to the gene trap is incomplete, and
approximately 15–20% of the Vrk1 transcripts splice around
the trap and express full-length VRK1. Thus, the GT3/GT3
mice are, in fact, hypomorphic for VRK1.
Examination of hypomorphic models has been extremely
useful for highlighting cell types and pathways that are most
sensitive to the loss of a protein while leaving many other
tissues unaffected. For example, complete disruption of the
LKB1 and PDK1 kinases causes embryonic arrest, but
hypomorphic (10–20% of wild-type levels) expression of
these kinases is sufficient to support development and allow
further study of the kinases [33, 34]. Likewise, our work
shows that diminished VRK1 expression has no apparent
impact on development, is compatible with viability, and is
well tolerated by many tissues and organs. Given the
demonstration that VRK is essential in other model organisms,
we believe that the hypomorphic nature of the GT3 allele
enabled us to avoid an embryonic lethal phenotype and
uncover the vital role of VRK1 in spermatogenesis. The fact
that the mice are viable and healthy may suggest VRK1 is less
important in other tissues, perhaps because of redundancy
within the VRK family or with other Ser/Thr protein kinases.
The protein most similar to VRK1 is VRK2, which may be
able to fulfill some of the roles played by VRK1. Interestingly,
a possible role for VRK2 itself in spermatogenesis was
suggested by the fact that Pog / mice, which lack the Pog
(proliferation of germ cells) gene, have a milder infertility
defect than gsd (germ-cell deficient) mice, which lack both
Pog and the adjacent Vrk2 gene [35].
Our observation that VRK1 was expressed in Sertoli cells
and spermatogonia extends an initial report of human VRK1
expression within seminiferous tubules [36]. Our expression
data, combined with the infertility of GT3/GT3 mice, led us to
examine the impact of VRK1 deficiency on spermatogenesis.
Gross examination of GT3/GT3 testes indicated that in
postpubertal mice, these testes were significantly smaller than
those of their þ/þ counterparts. Subsequent histological
analysis of these testes was extremely informative, because
the cell types responsible for spermatogenesis can be readily
observed in each seminiferous tubule. Briefly, undifferentiated
(type A) spermatogonial stem cells are found at the periphery
of the tubule along with the Sertoli cells. Spermatogonial stem
cells are capable of both self-renewal and differentiation;
expression of the transcription factor ZBTB16 is a defining
characteristic of these cells [28, 29]. Differentiation produces
type B spermatogonia; these cells express markers such as KIT
and PCNA and form the population that will undergo meiosis.
As the early meiotic cells known as primary spermatocytes
become secondary spermatocytes and then spermatids, they
move continually closer to the lumen of the tubule. By
determining which cell types were absent in the GT3/GT3
testes, we sought to pinpoint the steps at which VRK1
expression was critical. In young males 2–6 wk of age, little
difference could be observed between the þ/þ and GT3/GT3
testes. Both þ/þ and GT3/GT3 mice possessed all cell types
expected to be present at a particular time in development,
leading us to conclude that VRK1 deficiency does not impede
the first postnatal wave of spermatogenesis that occurs during
this time. However, during the next few weeks, the GT3/GT3
mice exhibit a progressive loss of GCNAþ, PCNAþ, and
KITþ premeiotic cells. As a result, all later stages of meiotic
cells were also progressively depleted. However, the pool of
undifferentiated ZBTB16þ cells remained constant over this
time period. Thus, VRK1 is not necessary to maintain the
earliest spermatogonial lineage, unlike the transcriptional
repressor ZBTB16 [28, 29]. Therefore, we postulate that
VRK1 is needed either for the differentiation of type A
spermatogonial stem cells into type B spermatogonia, the
ongoing proliferation of type B cells required for the
homeostasis of the precursor population, or both. In this
regard, the phenotype of VRK1-deficient mice is similar to that
of mice lacking either the Sohlh-1 or -2 transcriptional
regulators; the testes of mice lacking these proteins retain
ZBTB16þ cells but lack other differentiated cell types [37, 38].
However, whereas the expression of Sohlh-1 or -2 is limited to
spermatogonia, VRK1 appears to be expressed both in Sertoli
cells and in the basal layer of spermatogonia. This expression
profile indicates that the loss of the differentiating pool of
spermatogonia in VRK1-deficient testes might be the result of
a cell-autonomous role for VRK1 in spermatogonial differen-
tiation and/or proliferation. Alternatively, wild-type levels of
VRK1 expression in the supporting Sertoli cells might be
needed for them to provide the requisite signals to the
spermatogonia. Such a requirement has been found for the
Sertoli-specific factors ERM and Kit ligand (KITL), the
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absence of which can lead to a ‘‘Sertoli Cell Only’’ phenotype
in the seminiferous tubules of adult mice [39–41]. Distinguish-
ing between these two possibilities is an important goal for
future studies. However, semiquantitative RT-PCR analysis
revealed no significant difference in the expression of KL
between þ/þ and GT3/GT3 testis (Supplemental Fig. S6),
suggesting that the VRK1-deficient Sertoli cells retain the
ability to express at least this critical paracrine factor.
On a molecular level, the impact of VRK1 depletion likely
is multifactorial. The VRK1/BAF pathway has been examined
in mammalian tissue culture and has been documented via
genetic analysis of model organisms [16, 23]. VRK1-mediated
phosphorylation of BAF inhibits its ability to bind DNA and
interact with protein partners. Thus, dynamic phosphorylation
of BAF likely is a positive regulator of nuclear envelope
breakdown and a negative regulator of nuclear envelope
reformation and of BAF-mediated recruitment of chromatin to
the nuclear periphery. Indeed, in C. elegans, VRK1 depletion
has been shown to reduce BAF phosphorylation and to cause
defects in nuclear envelope reformation at the end of mitosis.
Aberrant nuclear envelope structures were also observed upon
expression of a BAF mutant that exhibited reduced phosphor-
ylation in comparison to the wild-type protein, providing
correlative evidence that the VRK1-BAF pathway is causing
the observed phenotype. In D. melanogaster, comparable
sterility phenotypes are seen upon depletion of VRK1 or
expression of a nonphosphorylatable variant of BAF [23]. In
both cases, formation of the meiotic karyosome is impeded by
aberrant recruitment of the chromosomes to the nuclear
periphery. It seems highly likely that the VRK/BAF axis will
be evolutionarily conserved, and that future studies will
confirm VRK1-mediated phosphorylation of BAF plays
important roles in mitosis and meiosis by regulating nuclear
envelope dynamics.
Murine VRK1 may exert a pro-proliferative role by
phosphorylating other substrates in mitosis or, indeed, during
distinct phases of the cell cycle. Phosphorylation of histone H3
has been reported; this phosphorylation would be likely to
affect chromosome condensation during mitosis. VRK1 has
recently been shown to interact with RAN and with polo-like
kinase 3 [42, 43]. RAN not only is involved in nucleocyto-
plasmic transport but also plays an important role in mitotic
spindle assembly and chromosome segregation [44]; PLK3 is
implicated in a signaling cascade that affects microtubule
dynamics [45] as well as Golgi fragmentation [46]. VRK1 has
also been reported to phosphorylate and activate the transcrip-
tion factor CREB, which stimulates the expression of cyclin D,
an important mediator of the G
1
/S transition. This pathway may
also be important in the pro-proliferative role of VRK1.
Although the present study is focused solely on the male
infertility defect in the hypomorphic Vrk1 mice, it is also
intriguing that VRK1 is highly expressed in the spleen and that
the proliferative markers PCNA and phosphohistone
H3(Ser10) are greatly reduced in the spleens of VRK1-
deficient mice. These data suggest that other proliferative
pathways, such as erythropoiesis, which occurs in the murine
spleen, might be impaired in the VRK1-deficient mice.
Moreover, our studies indicate that female mice homozygous
for the hypomorphic Vrk1 allele are also infertile. It will be of
great interest to determine the basis for this infertility. The
studies described herein indicate that VRK1 plays essential and
evolutionarily conserved roles in gametogenesis and fertility in
worms, flies, and mammals. The VRK1-deficient line of mice
that we have established will provide a fruitful system with
which to examine the important contributions of this kinase to
cell proliferation and gametogenesis.
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